Shuo Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shuo Chen has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Yang He
Department of Oral and Maxillofacial Surgery Peking University School and Hospital of Stomatology Beijing China
14 shared publications - Jie Wang
Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing, China
4 shared publications - Yi Zhang
Department of Oral and Maxillofacial Surgery, Peking University School of Stomatology, Beijing 100081, China
4 shared publications - Xinyu Wang
Department of Oral and Maxillofacial Surgery Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices Beijing China
3 shared publications - Bimeng Jie
Beijing Key Laboratory of Digital Stomatology, National Engineering Laboratory for Digital and Material Technology of Stomatology, National Clinical Research Center for Oral Diseases, Peking University School and Hospital of Stomatology, Beijing 100081, China
2 shared publications - Hao Tang
Department of Oral and Maxillofacial Surgery Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterials and Digital Medical Devices Beijing China
2 shared publications
Latest Publications
- Open Access
Heterogeneity and Fate Regulation of Fibrocartilage Stem Cells
The temporomandibular joint (TMJ) is one of the most complex and most frequently used synovial joints. The condylar surface is covered by a distinctive type of fibrocartilage that possesses a remarkable capacity for adaptive remodeling. In recent years, with rapid advances of single-cell transcriptomics and in vivo lineage-tracing technologies, fibrocartilage stem cells (FCSCs) residing in the superficial layer of the mandibular condyle have been demonstrated to play a decisive role in TMJ development, homeostasis, and the pathological progression of temporomandibular joint osteoarthritis (TMJOA). However, FCSCs do not constitute a single homogeneous population but rather exhibit substantial lineage heterogeneity. Under the spatiotemporal orchestration of distinct mechanical microenvironments and molecular signaling networks, different subpopulations of stem/progenitor cells adopt divergent fate trajectories toward chondrogenic or osteogenic differentiation. This review focuses on the cellular heterogeneity of FCSCs and the regulatory mechanisms governing their fate determination, summarizing recent advances in the field and discussing the translational potential of these findings for TMJ regenerative medicine and targeted therapeutic strategies.
Open AccessHeterogeneity and Fate Regulation of Fibrocartilage Stem Cells
The temporomandibular joint (TMJ) is one of the most complex and most frequently used synovial joints. The condylar surface is covered by a distinctive type of fibrocartilage that possesses a remarkable capacity for adaptive remodeling. In recent years, with rapid advances of single-cell transcriptomics and in vivo lineage-tracing technologies, fibrocartilage stem cells (FCSCs) residing in the superficial layer of the mandibular condyle have been demonstrated to play a decisive role in TMJ development, homeostasis, and the pathological progression of temporomandibular joint osteoarthritis (TMJOA). However, FCSCs do not constitute a single homogeneous population but rather exhibit substantial lineage heterogeneity. Under the spatiotemporal orchestration of distinct mechanical microenvironments and molecular signaling networks, different subpopulations of stem/progenitor cells adopt divergent fate trajectories toward chondrogenic or osteogenic differentiation. This review focuses on the cellular heterogeneity of FCSCs and the regulatory mechanisms governing their fate determination, summarizing recent advances in the field and discussing the translational potential of these findings for TMJ regenerative medicine and targeted therapeutic strategies.
- Open Access
Temporomandibular Joint Defects: Etiology and Reconstruction Strategy: A Narrative Review
Temporomandibular joint (TMJ) defects primarily arise from congenital malformations, bony ankylosis, and radical tumor resection. As a pivotal structure for regulating maxillofacial development and maintaining stomatognathic homeostasis, the anatomical restoration and functional reconstruction of the TMJ are essential for rehabilitating the dentofacial complex. Distinct from standard mandibular reconstruction, TMJ reconstruction is inherently more complex, with treatment heavily dependent on etiology, age, defect extent, and coexisting dentofacial deformities—factors that invariably require patient-specific protocols. This review systematically evaluates current reconstructive paradigms, including free bone grafting (costochondral and coronoid process grafting, vertical ramus osteotomy), vascularized free flaps (vascularized fibula, vascularized medial femoral condyle, and deep circumflex iliac artery flaps), mandibular ramus distraction osteogenesis, and total joint replacement. We provide a critical analysis of their respective clinical indications, advantages, and limitations, while discussing emerging trends and future perspectives in the field.
Open AccessTemporomandibular Joint Defects: Etiology and Reconstruction Strategy: A Narrative Review
Temporomandibular joint (TMJ) defects primarily arise from congenital malformations, bony ankylosis, and radical tumor resection. As a pivotal structure for regulating maxillofacial development and maintaining stomatognathic homeostasis, the anatomical restoration and functional reconstruction of the TMJ are essential for rehabilitating the dentofacial complex. Distinct from standard mandibular reconstruction, TMJ reconstruction is inherently more complex, with treatment heavily dependent on etiology, age, defect extent, and coexisting dentofacial deformities—factors that invariably require patient-specific protocols. This review systematically evaluates current reconstructive paradigms, including free bone grafting (costochondral and coronoid process grafting, vertical ramus osteotomy), vascularized free flaps (vascularized fibula, vascularized medial femoral condyle, and deep circumflex iliac artery flaps), mandibular ramus distraction osteogenesis, and total joint replacement. We provide a critical analysis of their respective clinical indications, advantages, and limitations, while discussing emerging trends and future perspectives in the field.
- 13 August 2026
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 30 (9) , 387
Three-dimensional spatiotemporal analysis of condylar remodeling after conservative treatment of pediatric mandibular condylar sagittal fractures
- 13 August 2026
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 30 (9) , 387
Three-dimensional spatiotemporal analysis of condylar remodeling after conservative treatment of pediatric mandibular condylar sagittal fractures
- Open Access
- 3 June 2026
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 9 (8) , e202603772
A novel SLC2A10 gain-of-function variant links glycolytic macrophage polarization to chronic nonbacterial osteomyelitis
Chronic nonbacterial osteomyelitis is a rare autoinflammatory bone disorder with unclear etiology. In a Chinese family, whole-exome sequencing identified a heterozygous missense variant in SLC2A10 that cosegregated with disease. Structural modeling suggested that the substitution disrupts hydrogen bond within the transmembrane domain, potentially altering glucose transport activity. In vitro, the expression of the p.Asp292Glu variant in macrophages enhanced glucose uptake, increased glycolytic activity, and promoted pro-inflammatory polarization, accompanied by increased production of inflammatory mediators. The variant also accelerated osteoclast differentiation and suppressed osteoblast-mediated mineralization, indicating a disruption of bone homeostasis. Zebrafish expressing the p.Asp292Glu variant exhibited enhanced inflammatory responses, increased reactive oxygen species accumulation, elevated macrophage infiltration in the mandibular region, and impaired bone mineralization. Transcriptomic analysis confirmed activation of glycolytic and inflammatory signaling pathways, as well as enrichment of osteoclast differentiation networks. These findings demonstrate that the SLC2A10 variant exerts a gain-of-function effect driving glycolysis-dependent macrophage polarization and osteoclastogenesis, leading to chronic inflammatory bone destruction. This study broadens the genetic understanding of chronic nonbacterial osteomyelitis and suggests a potential therapeutic target.
- 3 June 2026
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 9 (8) , e202603772
Open AccessA novel SLC2A10 gain-of-function variant links glycolytic macrophage polarization to chronic nonbacterial osteomyelitis
Chronic nonbacterial osteomyelitis is a rare autoinflammatory bone disorder with unclear etiology. In a Chinese family, whole-exome sequencing identified a heterozygous missense variant in SLC2A10 that cosegregated with disease. Structural modeling suggested that the substitution disrupts hydrogen bond within the transmembrane domain, potentially altering glucose transport activity. In vitro, the expression of the p.Asp292Glu variant in macrophages enhanced glucose uptake, increased glycolytic activity, and promoted pro-inflammatory polarization, accompanied by increased production of inflammatory mediators. The variant also accelerated osteoclast differentiation and suppressed osteoblast-mediated mineralization, indicating a disruption of bone homeostasis. Zebrafish expressing the p.Asp292Glu variant exhibited enhanced inflammatory responses, increased reactive oxygen species accumulation, elevated macrophage infiltration in the mandibular region, and impaired bone mineralization. Transcriptomic analysis confirmed activation of glycolytic and inflammatory signaling pathways, as well as enrichment of osteoclast differentiation networks. These findings demonstrate that the SLC2A10 variant exerts a gain-of-function effect driving glycolysis-dependent macrophage polarization and osteoclastogenesis, leading to chronic inflammatory bone destruction. This study broadens the genetic understanding of chronic nonbacterial osteomyelitis and suggests a potential therapeutic target.
- 19 May 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (10)
Cover Image
- 18 May 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (10) , e71903
Yap/Taz Orchestrates Chondrocyte Differentiation Fate in Fibrocartilage Development
The condyle is a key growth center of the mandible, covered by a layer of fibrocartilage. Through endochondral ossification, condylar cartilage drives mandibular elongation and height increase. However, the precise regulatory mechanism underlying this process remains unclear. In this study, we employed Aggrecan(Acan)‐Cre ERT2 ; Yap fl/fl ; Taz fl/fl mice to investigate the consequences of Yap/Taz deletion on chondrocyte differentiation and endochondral ossification during postnatal fibrocartilage development. Histological analysis revealed that the loss of Yap/Taz reduced the proportions of the superficial and proliferative zones but increased that of the hypertrophic layer. Micro‐CT analysis further showed that condylar height and subchondral bone formation were significantly decreased. Col X+ hypertrophic chondrocytes exhibited a stacked arrangement, yet failed to support endochondral ossification. Mechanistically, deletion of Yap/Taz likely suppresses Runx2 expression, thereby impairing the transdifferentiation potential of hypertrophic chondrocytes into osteoblasts. Collectively, these findings demonstrate that Yap/Taz inhibits chondrocyte maturation during chondrocyte differentiation while promoting chondrocyte transdifferentiation into osteoblasts at the subsequent endochondral ossification stage.
- 18 May 2026
- Published by Wiley in The FASEB Journal
- Vol. 40 (10) , e71903
Yap/Taz Orchestrates Chondrocyte Differentiation Fate in Fibrocartilage Development
The condyle is a key growth center of the mandible, covered by a layer of fibrocartilage. Through endochondral ossification, condylar cartilage drives mandibular elongation and height increase. However, the precise regulatory mechanism underlying this process remains unclear. In this study, we employed Aggrecan(Acan)‐Cre ERT2 ; Yap fl/fl ; Taz fl/fl mice to investigate the consequences of Yap/Taz deletion on chondrocyte differentiation and endochondral ossification during postnatal fibrocartilage development. Histological analysis revealed that the loss of Yap/Taz reduced the proportions of the superficial and proliferative zones but increased that of the hypertrophic layer. Micro‐CT analysis further showed that condylar height and subchondral bone formation were significantly decreased. Col X+ hypertrophic chondrocytes exhibited a stacked arrangement, yet failed to support endochondral ossification. Mechanistically, deletion of Yap/Taz likely suppresses Runx2 expression, thereby impairing the transdifferentiation potential of hypertrophic chondrocytes into osteoblasts. Collectively, these findings demonstrate that Yap/Taz inhibits chondrocyte maturation during chondrocyte differentiation while promoting chondrocyte transdifferentiation into osteoblasts at the subsequent endochondral ossification stage.
- Open Access
Sunitinib Impairs Oral Mucosal Healing Through Endoplasmic Reticulum Stress-Mediated Keratinocyte Dysfunction
Medication-related osteonecrosis of the jaw (MRONJ) is a severe adverse event triggered by antiresorptive and/or anti-angiogenic agents, characterized by bone destruction, sequestrum formation, and refractory mucosal defects. Effective mucosal healing can be a critical factor for MRONJ prevention and treatment. While endoplasmic reticulum stress (ER stress) has been implicated in tissue repair, its role in MRONJ-associated mucosal healing impairment remains undefined. This study investigated the effects of the anti-angiogenic drug sunitinib on oral mucosal healing and its underlying mechanisms. A mouse model of palatal mucosal defects was established, RNA-seq, transmission electron microscopy, and morphological analyses were used to assess how sunitinib affects ER function during mucosal repair. Using human oral keratinocytes (HOKs), we further elucidated the subcellular mechanisms through which sunitinib influences cell proliferation, migration, cell cycle progression, tight junctions, and apoptosis via techniques such as qPCR, Western blotting, immunofluorescence, and flow cytometry. Our findings demonstrated that sunitinib might induce significant alterations in the morphology of the ER and mitochondria. Both in vivo and in vitro experiments revealed that sunitinib persistently activates the GRP78 (BIP)/PERK/ATF4/CHOP axis in HOKs. This sustained ER stress can inhibit keratinocytes migration and proliferation, disrupt tight junctions, and trigger the intrinsic mitochondrial apoptotic pathway, ultimately leading to impaired oral mucosal healing and barrier dysfunction. Critically, pharmacological inhibition of ER stress was shown to restore keratinocytes’ function and promote effective mucosal healing. These results indicated that targeting sunitinib-induced persistent ER stress might represent a promising therapeutic strategy to prevent and treat oral mucosal toxicity associated with this drug.
Open AccessSunitinib Impairs Oral Mucosal Healing Through Endoplasmic Reticulum Stress-Mediated Keratinocyte Dysfunction
Medication-related osteonecrosis of the jaw (MRONJ) is a severe adverse event triggered by antiresorptive and/or anti-angiogenic agents, characterized by bone destruction, sequestrum formation, and refractory mucosal defects. Effective mucosal healing can be a critical factor for MRONJ prevention and treatment. While endoplasmic reticulum stress (ER stress) has been implicated in tissue repair, its role in MRONJ-associated mucosal healing impairment remains undefined. This study investigated the effects of the anti-angiogenic drug sunitinib on oral mucosal healing and its underlying mechanisms. A mouse model of palatal mucosal defects was established, RNA-seq, transmission electron microscopy, and morphological analyses were used to assess how sunitinib affects ER function during mucosal repair. Using human oral keratinocytes (HOKs), we further elucidated the subcellular mechanisms through which sunitinib influences cell proliferation, migration, cell cycle progression, tight junctions, and apoptosis via techniques such as qPCR, Western blotting, immunofluorescence, and flow cytometry. Our findings demonstrated that sunitinib might induce significant alterations in the morphology of the ER and mitochondria. Both in vivo and in vitro experiments revealed that sunitinib persistently activates the GRP78 (BIP)/PERK/ATF4/CHOP axis in HOKs. This sustained ER stress can inhibit keratinocytes migration and proliferation, disrupt tight junctions, and trigger the intrinsic mitochondrial apoptotic pathway, ultimately leading to impaired oral mucosal healing and barrier dysfunction. Critically, pharmacological inhibition of ER stress was shown to restore keratinocytes’ function and promote effective mucosal healing. These results indicated that targeting sunitinib-induced persistent ER stress might represent a promising therapeutic strategy to prevent and treat oral mucosal toxicity associated with this drug.
- 24 June 2025
- Published by Wiley in Oral Diseases
- Vol. 31 (12) , 3383-3394
YAP Deficiency in Gli1 + Osteogenic Progenitors Leads to Condylar Hypoplasia via β‐Catenin Signaling
Objectives: The pathogenesis of mandibular condylar hypoplasia has not been fully understood. Our previous studies provided evidence that Gli1 + osteogenic progenitors contribute to condylar development. This study aimed to investigate the role of YAP in Gli1 + cells during condylar development. Methods: We generated Gli1‐Cre ERT2 ; Yap fl/fl mice, in which tamoxifen (TMX) was used to induce the deletion of Yap in Gli1 + cells. CHIR injection was to activate β‐catenin signaling. Microscopic photography, Micro‐CT, hematoxylin–eosin (H&E) staining, immunofluorescence (IF) staining, Real‐time quantitative polymerase chain reaction (RT‐qPCR), tartrate‐resistant acid phosphatase (TRAP) staining and calcein‐alizarin red double labeling were conducted for analyses. Chromatin immunoprecipitation (ChIP) assay was used to investigate the molecular mechanism involved. Results: YAP co‐localized with mandibular condylar Gli1 + osteogenic progenitors. After induction, Gli1‐Cre ERT2 ; Yap fl/fl mice suffered from condylar hypoplasia characterized by reduced bone mass and impaired osteogenesis due to decreased cell proliferation. ChIP‐qPCR analysis, RT‐qPCR analysis, and immunofluorescence staining further proved that YAP could directly regulate the expression of β‐catenin. Functionally, pharmacological activation of β‐catenin signaling successfully alleviated condylar hypoplasia in Gli1‐Cre ERT2 ; Yap fl/fl mice. Conclusions: Our study demonstrated that the YAP/β‐catenin axis mediated osteogenesis in Gli1 + osteogenic progenitors during condylar development, which may provide a potential target for the treatment of condylar hypoplasia.
- 24 June 2025
- Published by Wiley in Oral Diseases
- Vol. 31 (12) , 3383-3394
YAP Deficiency in Gli1 + Osteogenic Progenitors Leads to Condylar Hypoplasia via β‐Catenin Signaling
Objectives: The pathogenesis of mandibular condylar hypoplasia has not been fully understood. Our previous studies provided evidence that Gli1 + osteogenic progenitors contribute to condylar development. This study aimed to investigate the role of YAP in Gli1 + cells during condylar development. Methods: We generated Gli1‐Cre ERT2 ; Yap fl/fl mice, in which tamoxifen (TMX) was used to induce the deletion of Yap in Gli1 + cells. CHIR injection was to activate β‐catenin signaling. Microscopic photography, Micro‐CT, hematoxylin–eosin (H&E) staining, immunofluorescence (IF) staining, Real‐time quantitative polymerase chain reaction (RT‐qPCR), tartrate‐resistant acid phosphatase (TRAP) staining and calcein‐alizarin red double labeling were conducted for analyses. Chromatin immunoprecipitation (ChIP) assay was used to investigate the molecular mechanism involved. Results: YAP co‐localized with mandibular condylar Gli1 + osteogenic progenitors. After induction, Gli1‐Cre ERT2 ; Yap fl/fl mice suffered from condylar hypoplasia characterized by reduced bone mass and impaired osteogenesis due to decreased cell proliferation. ChIP‐qPCR analysis, RT‐qPCR analysis, and immunofluorescence staining further proved that YAP could directly regulate the expression of β‐catenin. Functionally, pharmacological activation of β‐catenin signaling successfully alleviated condylar hypoplasia in Gli1‐Cre ERT2 ; Yap fl/fl mice. Conclusions: Our study demonstrated that the YAP/β‐catenin axis mediated osteogenesis in Gli1 + osteogenic progenitors during condylar development, which may provide a potential target for the treatment of condylar hypoplasia.
- Open Access
- 30 May 2025
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 26 (1) , 1-12
Wnt/β-catenin regulates Gli1 + osteogenic progenitors in condylar subchondral bone development and osteoarthritis
Gli1 has been identified as a marker of osteogenic progenitors in the condylar subchondral bone. The Wnt/β-catenin signaling pathway is known to regulate stem cell proliferation and differentiation in bone. Whether Wnt/β-catenin signaling pathway could influence Gli1 + osteogenic progenitors remains unclear. Here, we aimed to investigate the role and related mechanisms of Wnt/β-catenin signaling in the regulation of Gli1 + osteogenic progenitors in condylar development and temporomandibular joint osteoarthritis (TMJOA). We generated Gli1-CreERT2;tdTomato mice to perform lineage tracing; We generated Gli1-CreERT2; β-cateninfl/fl mice, in which β-catenin was lost in the Gli1 + lineage to examine the role of Wnt/β-catenin signaling pathway in regulating the proliferation and differentiation of Gli1 + cells. The β-catenin CKO mice and their wild-type (WT) littermates were induced at 3 days and were euthanized 1, 2 or 4 weeks after induction; We induced a TMJOA model through a unilateral partial discectomy (UPD) of the temporomandibular joint disc in 6-week-old tamoxifen-treated Gli1-CreERT2;β-cateninfl/fl;tdTomato mice and control group (Gli1-CreERT2;tdTomato mice). We harvested the mandibles at 4 weeks post-surgery. Conditional knockout of β-catenin inhibited the osteogenic activity of Gli1 + progenitor cells during condylar subchondral bone development. In discectomy-induced TMJOA, the overactivation of Gli1 in subchondral bone drove pathological osteogenesis and aberrant subchondral bone remodeling. Deletion of β-catenin in Gli1 + cells mitigated excessive Gli1 + cells activation and ectopic mineralization. Our findings establish Wnt/β-catenin signaling as a key regulator of Gli1 + progenitor cell fate determination in both bone development and TMJOA pathogenesis.
- 30 May 2025
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 26 (1) , 1-12
Open AccessWnt/β-catenin regulates Gli1 + osteogenic progenitors in condylar subchondral bone development and osteoarthritis
Gli1 has been identified as a marker of osteogenic progenitors in the condylar subchondral bone. The Wnt/β-catenin signaling pathway is known to regulate stem cell proliferation and differentiation in bone. Whether Wnt/β-catenin signaling pathway could influence Gli1 + osteogenic progenitors remains unclear. Here, we aimed to investigate the role and related mechanisms of Wnt/β-catenin signaling in the regulation of Gli1 + osteogenic progenitors in condylar development and temporomandibular joint osteoarthritis (TMJOA). We generated Gli1-CreERT2;tdTomato mice to perform lineage tracing; We generated Gli1-CreERT2; β-cateninfl/fl mice, in which β-catenin was lost in the Gli1 + lineage to examine the role of Wnt/β-catenin signaling pathway in regulating the proliferation and differentiation of Gli1 + cells. The β-catenin CKO mice and their wild-type (WT) littermates were induced at 3 days and were euthanized 1, 2 or 4 weeks after induction; We induced a TMJOA model through a unilateral partial discectomy (UPD) of the temporomandibular joint disc in 6-week-old tamoxifen-treated Gli1-CreERT2;β-cateninfl/fl;tdTomato mice and control group (Gli1-CreERT2;tdTomato mice). We harvested the mandibles at 4 weeks post-surgery. Conditional knockout of β-catenin inhibited the osteogenic activity of Gli1 + progenitor cells during condylar subchondral bone development. In discectomy-induced TMJOA, the overactivation of Gli1 in subchondral bone drove pathological osteogenesis and aberrant subchondral bone remodeling. Deletion of β-catenin in Gli1 + cells mitigated excessive Gli1 + cells activation and ectopic mineralization. Our findings establish Wnt/β-catenin signaling as a key regulator of Gli1 + progenitor cell fate determination in both bone development and TMJOA pathogenesis.